keyword
https://read.qxmd.com/read/38652688/correction-sex-differences-in-age-related-loss-of-kidney-function
#1
JOURNAL ARTICLE
Toralf Melsom, Norvik Jon Viljar, Inger Therese Enoksen, Vidar Stefansson, Ulla Dorte Mathisen, Ole Martin Fuskevåg, Trond G Jenssen, Marit D Solbu, Bjørn O Eriksen
No abstract text is available yet for this article.
April 23, 2024: Journal of the American Society of Nephrology: JASN
https://read.qxmd.com/read/38652567/acute-kidney-injury-receiving-dialysis-and-dialysis-care-following-hospital-discharge
#2
JOURNAL ARTICLE
Seda Babroudi, Daniel E Weiner, Javier A Neyra, David A Drew
The number of individuals with acute kidney injury receiving outpatient dialysis (AKI-D) is increasing. At present, based on limited data, approximately one third of individuals with AKI-D who receive outpatient dialysis after hospital discharge survive and regain sufficient kidney function to discontinue dialysis. Data to inform dialysis management strategies that promote kidney function recovery and processes of care among individuals with AKI-D receiving outpatient dialysis are lacking. In this article, we detail current trends in the incidence, risk factors, clinical outcomes, proposed management, and health policy landscape for individuals with AKI-D receiving outpatient dialysis and identify areas for further research...
April 23, 2024: Journal of the American Society of Nephrology: JASN
https://read.qxmd.com/read/38652562/american-society-of-nephrology-kidney-treks-program
#3
JOURNAL ARTICLE
Molly Rubin, Stewart H Lecker, Nirupama Ramkumar, Stephen M Sozio, Robert S Hoover, Mark L Zeidel, Benjamin S Ko
In response to decreasing numbers of individuals entering into nephrology fellowships, the American Society of Nephrology launched Kidney TREKS (Tutored Research and Education for Kidney Scholars) to stimulate interest in nephrology among medical students, graduate students, and postdoctoral fellows. The program combines a one-week intensive exposure to kidney physiology with a longitudinal mentorship program at the participants' home institutions. Ten years in, an analysis was conducted to assess its effectiveness...
April 23, 2024: Journal of the American Society of Nephrology: JASN
https://read.qxmd.com/read/38652558/a-tryptophan-derived-uremic-metabolite-ahr-pdk4-axis-governs-skeletal-muscle-mitochondrial-energetics-in-chronic-kidney-disease
#4
JOURNAL ARTICLE
Trace Thome, Nicholas A Vugman, Lauren E Stone, Keon Wimberly, Salvatore T Scali, Terence E Ryan
Chronic kidney disease (CKD) causes an accumulation of uremic metabolites that negatively impact skeletal muscle function. Tryptophan-derived uremic metabolites are agonists of the aryl hydrocarbon receptor (AHR) which has been shown to be activated in the blood of CKD patients. This study investigated the role of the AHR in skeletal muscle pathology of CKD. Compared to control participants with normal kidney function, AHR-dependent gene expression (CYP1A1 and CYP1B1) was significantly upregulated in skeletal muscle of patients with CKD (P=0...
April 23, 2024: JCI Insight
https://read.qxmd.com/read/38652545/spatiotemporal-landscape-of-kidney-tubular-responses-to-glomerular-proteinuria
#5
JOURNAL ARTICLE
Anna Faivre, Milica Bugarski, Anna Rinaldi, Imene B Sakhi, Thomas Verissimo, David Legouis, Sara Correia, Monika Kaminska, Delal Dalga, Daniele Malpetti, Pietro E Cippa, Sophie de Seigneux, Andrew M Hall
BACKGROUND: Large increases in glomerular protein filtration induce major changes in body homeostasis and increase risk of kidney functional decline and cardiovascular disease. We investigated how elevated protein exposure modifies the landscape of tubular function along the entire nephron, to understand the cellular changes that mediate these important clinical phenomena. METHODS: We conducted single nuclei RNA sequencing, functional intravital imaging, and antibody staining to spatially map transport processes along the mouse kidney tubule...
April 24, 2024: Journal of the American Society of Nephrology: JASN
https://read.qxmd.com/read/38652137/kidney-outcomes-in-children-with-primary-focal-segmental-glomerulosclerosis-from-a-low-and-middle-income-country
#6
JOURNAL ARTICLE
Kolluri Priyanka, Bobbity Deepthi, Sudarsan Krishnasamy, Rajesh Nachiappa Ganesh, Madhileti Sravani, Sriram Krishnamurthy
BACKGROUND: Limited data exists regarding the clinical course and outcomes of children with primary focal segmental glomerulosclerosis (FSGS) from low- and middle- income countries. METHODS: Children aged 1-18 years with biopsy-proven primary FSGS followed from January 2010-June 2023 in a tertiary-care center were enrolled and their clinical profile, histological characteristics, kidney outcomes, and predictors of adverse outcomes were determined. RESULTS: Over 13 years, 73 (54...
April 23, 2024: Pediatric Nephrology
https://read.qxmd.com/read/38651491/skeletal-parathyroid-hormone-hyporesponsiveness-a-neglected-but-clinically-relevant-reality-in-chronic-kidney-disease
#7
JOURNAL ARTICLE
Pieter Evenepoel, Hanne Skou Jørgensen
PURPOSE OF REVIEW: Defining the optimal parathyroid hormone (PTH) target in chronic kidney disease (CKD) is challenging, especially for bone outcomes, due to the substantial variability in the skeleton's response to PTH. Although PTH hyporesponsiveness is as integral a component of CKD-mineral bone disorder as elevated PTH levels, clinical awareness of this condition is limited. In this review, we will discuss factors and mechanisms contributing to PTH hyporesponsiveness in CKD. This knowledge may provide clues towards a personalized approach to treating secondary hyperparathyroidism in CKD...
April 24, 2024: Current Opinion in Nephrology and Hypertension
https://read.qxmd.com/read/38650537/clinical-conundrums-in-pediatric-kidney-transplantation-what-we-know-about-the-role-of-angiotensin-ii-type-i-receptor-antibodies-in-pediatric-kidney-transplantation-and-the-path-forward
#8
REVIEW
Meghan H Pearl
Antibodies to angiotensin II type 1 receptor (AT1R-Abs) are among the most well-studied non-HLA antibodies in renal transplantation. These antibodies have been shown to be common in pediatric kidney transplantation and associated with antibody-mediated rejection (AMR), vascular inflammation, development of human leukocyte donor-specific antibodies (HLA DSA), and allograft loss. As AT1R-Ab testing becomes more readily accessible, evidence to guide clinical practice for testing and treating AT1R-Ab positivity in pediatric kidney transplant recipients remains limited...
May 2024: Pediatric Transplantation
https://read.qxmd.com/read/38650079/kinetics-of-beta2-microglobulin-with-hemodiafiltration-and-high-flux-hemodialysis
#9
JOURNAL ARTICLE
Richard A Ward, John T Daugirdas
BACKGROUND: A kinetic model for beta-2-microglobulin removal and generation was used to explore the impact of adding hemodiafiltration on predialysis and time-averaged serum values. METHODS: The model was tested on data from the HEMO study and on a sample of patients undergoing high-flux hemodialysis. The impact of hemodiafiltration on beta-2-microglobulin levels was evaluated by modeling four randomized studies of hemodiafiltration vs. hemodialysis. The impact of residual kidney function on beta-2-microglobulin was tested by comparing results of previously reported measured data with model predictions...
April 23, 2024: Clinical Journal of the American Society of Nephrology: CJASN
https://read.qxmd.com/read/38649939/contrast-induced-acute-kidney-injury-a-review-of-definition-pathogenesis-risk-factors-prevention-and-treatment
#10
REVIEW
Yanyan Li, Junda Wang
Contrast-induced acute kidney injury (CI-AKI) has become the third leading cause of hospital-acquired AKI, which seriously threatens the health of patients. To date, the precise pathogenesis of CI-AKI has remained not clear and may be related to the direct cytotoxicity, hypoxia and ischemia of medulla, and oxidative stress caused by iodine contrast medium, which have diverse physicochemical properties, including cytotoxicity, permeability and viscosity. The latest research shows that microRNAs (miRNAs) are also involved in apoptosis, pyroptosis, and autophagy which caused by iodine contrast medium (ICM), which may be implicated in the pathogenesis of CI-AKI...
April 22, 2024: BMC Nephrology
https://read.qxmd.com/read/38649936/clinical-significance-of-urinary-inflammatory-biomarkers-in-patients-with-iga-nephropathy
#11
JOURNAL ARTICLE
Soo-Young Yoon, Jin Sug Kim, Su Woong Jung, Yang Gyun Kim, Ju-Young Moon, Sang-Ho Lee, Sung-Vin Yim, Hyeon Seok Hwang, Kyunghwan Jeong
BACKGROUND: IgA nephropathy (IgAN) is the most common type of primary glomerulonephritis, although the definitive markers are unknown. We aimed to investigate the clinical significance of urinary cytokines in patients with IgAN. METHODS: From 2009 to 2018, the patients were divided into three groups: IgAN (n = 191), disease control (n = 53), and normal control (n = 76). We used a multiplex enzyme-linked immunosorbent assay to measure 16 selected urinary inflammatory cytokines, evaluated the correlation between clinical and pathological features following regression analysis on progression...
April 22, 2024: BMC Nephrology
https://read.qxmd.com/read/38649863/clinical-characteristics-and-outcomes-of-maintenance-hemodialysis-patients-with-covid-19-during-the-omicron-wave-of-the-pandemic-in-beijing-a-single-center-retrospective-study
#12
JOURNAL ARTICLE
Yujing Pan, Dan Li, Zhoucang Zhang, Jing Xu, Xinping Sun, Mei Wang, Jiaxiang Ding
BACKGROUND: The clinical manifestations and prognosis of hemodialysis patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) during the Omicron wave of the pandemic infection were still unclear. This study investigated the clinical characteristics of patients undergoing maintenance hemodialysis (MHD) infected with it. METHODS: This retrospective single-center study included 151 patients undergoing MHD. Healthcare workers were selected as control group were assessed from December 1, 2022 to March 31, 2023...
April 22, 2024: BMC Nephrology
https://read.qxmd.com/read/38649847/trajectories-of-atherosclerotic-cardiovascular-disease-risk-scores-as-a-predictor-for-incident-chronic-kidney-disease
#13
JOURNAL ARTICLE
Hye Sun Lee, Hong Il Lim, Tae Ju Moon, So Young Lee, Jun-Hyuk Lee
BACKGROUND: The relationship between atherosclerosis and renal function is well established. Atherosclerotic cardiovascular disease (ASCVD) risk scores reflect atherosclerotic burden, which changes over time. We investigated the association between ASCVD risk trajectories and incident chronic kidney disease (CKD) using data from a large community-based Korean cohort with up to 16 years of follow-up. METHODS: We analyzed data from 5032 participants without CKD from the baseline survey of the Korean Genome and Epidemiology Study Ansan-Ansung cohort...
April 22, 2024: BMC Nephrology
https://read.qxmd.com/read/38649831/a-loss-of-function-agtr1-variant-in-a-critically-ill-infant-with-renal-tubular-dysgenesis-case-presentation-and-literature-review
#14
JOURNAL ARTICLE
Aljazi Al-Maraghi, Waleed Aamer, Mubarak Ziab, Elbay Aliyev, Najwa Elbashir, Sura Hussein, Sasirekha Palaniswamy, Dhullipala Anand, Donald R Love, Adrian Charles, Ammira A S Akil, Khalid A Fakhro
BACKGROUND: Renal tubular dysgenesis (RTD) is a severe disorder with poor prognosis significantly impacting the proximal tubules of the kidney while maintaining an anatomically normal gross structure. The genetic origin of RTD, involving variants in the ACE, REN, AGT, and AGTR1 genes, affects various enzymes or receptors within the Renin angiotensin system (RAS). This condition manifests prenatally with oligohydramninos and postnatally with persistent anuria, severe refractory hypotension, and defects in skull ossification...
April 22, 2024: BMC Nephrology
https://read.qxmd.com/read/38649519/predictive-value-of-donor-kidney-quality-assessment-and-risk-quantification-scores-on-5-year-outcomes-of-deceased-donor-kidney-transplantation
#15
JOURNAL ARTICLE
Rui Zhi Ng, Chee Yong Ng, Terence Kee, Chang Yin Chionh
BACKGROUND: Due to the excess demand for deceased donor kidneys, risk quantification scores were developed to help with kidney allocation. The kidney donor risk index (KDRI) is used in the US kidney allocation system. We currently use expanded criteria (UNOS) and Remuzzi scoring for allocation of deceased donor kidneys and the utility of KDRI in our cohort is unknown. We aim to evaluate the association of KDRI with relation to 5 year graft and patient survival. METHODS: Retrospective cohort study of 225 adults who received a deceased donor kidney transplant between 1 Nov 2005 and 30 June 2014...
April 22, 2024: International Urology and Nephrology
https://read.qxmd.com/read/38649215/cholemic-nephropathy-role-in-acute-kidney-injury-in-cholestasis-and-cirrhosis
#16
REVIEW
Klemens Pinter, Alexander Rosenkranz
The concept of structural kidney damage and renal dysfunction as a result of jaundice attracted attention in the medical community in the early and mid-20th century. The postulated doctrine of the time was that the excretion of elevated concentrations of bile results in bile-stained casts occupying collecting and distal convoluted tubules, degeneration of tubular epithelium, and decreased renal function. Compared to the hepatorenal syndrome, the poster child of hepatology and nephrology collaboration, the notion of structural kidney damage and renal dysfunction as a result of cholemia lost its traction and has almost disappeared from modern textbooks...
March 2024: Adv Kidney Dis Health
https://read.qxmd.com/read/38647229/impact-of-american-diabetes-association-2022-guidelines-on-prescribing-rates-of-sodium-glucose-cotransporter-2-inhibitors-in-ambulatory-care-organization-patients-with-type-2-diabetes
#17
JOURNAL ARTICLE
Alexis R Bogannam, Ewan McNicol, Kevin DeLeonardo, Ashwini Ranade, Kathy Zaiken
Background: Recent clinical trials and guideline updates have highlighted the efficacy and safety of sodium-glucose cotransporter-2 inhibitor (SGLT2i) use in patients with type 2 diabetes (T2D) and comorbidities including atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease (CKD), or heart failure (HF). Objective: This study assesses the rates of guideline-based prescribing of SGLT2i in patients with T2D and one or more of the following comorbidities: ASCVD, CKD, or HF, prior to and after the 2022 American Diabetes Association (ADA) guideline publication within the Atrius Health clinical pharmacy, internal medicine, and specialty medicine departments...
April 22, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38647140/resilience-and-challenges-of-peritoneal-dialysis-survivors-in-the-aftermath-of-the-2023-kahramanmara%C3%A5-earthquake
#18
JOURNAL ARTICLE
Tuncay Sahutoglu, Ramazan Danis, Irem Pembegul, Ilyas Ozturk, Can Huzmeli, Murat Tugcu, Ebru Gok Oguz, Feyza Bora, Mahmud Islam, Yavuz Ayar, Zulfikar Yilmaz, Derya Basak Tanburoglu, Fatih Genc, Mehmet Emin Bindal, Serhan Tuglular, Rumeyza Kazancioglu
INTRODUCTION: Peritoneal dialysis (PD) remains understudied in disaster nephrology. This retrospective multicenter study explores the experiences of PD survivors following the February 6, 2023, Kahramanmaraş Earthquake. METHODS: Adult PD patients from 11 affected cities were analyzed to assess challenges faced during and postearthquake, alongside clinical outcomes. RESULTS: Among 101 participants (median age: 45 years, median PD duration: 24 months), 57 were female, with 79 on continuous ambulatory PD...
April 22, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38646905/pharmacotherapy-considerations-for-patients-who-develop-acute-kidney-injury-during-cancer-therapy
#19
REVIEW
Emanuele Parodi, Maura Rossi, Achille Bottiglieri, Marco Ladetto, Guido Merlotti, Vincenzo Cantaluppi, Marco Quaglia
INTRODUCTION: Acute kidney injury (AKI) frequently develops in patients receiving cancer therapy and requires a wide differential diagnosis due to possible role of unique cancer and drug-related factors, in addition to common pre- and post-renal causes. Rapid development of new molecular targeted anti-cancer drugs and immunotherapies has opened unprecedented possibilities of treatment at the price of an increased spectrum of renal side effects. AREAS COVERED: The present review aims at providing a state-of-the-art picture of AKI in cancer patient (PubMed and Embase libraries were searched from inception to January 2024), with a focus on differential diagnosis and management of diverse clinical settings...
April 22, 2024: Expert Opinion on Pharmacotherapy
https://read.qxmd.com/read/38646327/reusing-plasma-filters-in-resource-poor-settings-experience-from-a-tertiary-care-hospital
#20
JOURNAL ARTICLE
Priti Meena, Sandip Panda, Paromita Das, Anish Garg, Mohit Dayanandan
INTRODUCTION: Therapeutic plasma exchange (TPE) is used to manage various life-threatening illnesses. It is widely performed by nephrologists, intensivists, pathologists, or experts in transfusion medicine worldwide. However, the costs of TPE sessions are exceedingly high, and they have a huge impact on patients' financial burden. Herein, we investigated the outcomes of the reuse of plasma filters in TPE on several occasions. METHODS: This is a retrospective analysis of patients receiving TPE from January 1, 2020, to April 30, 2023, in the Department of Nephrology...
March 2024: Curēus
keyword
keyword
1370
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.